Evaluation of Melanotan-II

“Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study.”¹

1.
Dorr RT, Lines R, Levine N, et al. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences. Published online April 1996:1777-1784. doi:10.1016/0024-3205(96)00160-9

Dr. Ruskin R. Lines, MD Melanotan 2
Dermatologist in Gilbert, Arizona. He has been in practice for over 20 years
Ruskin R. Lines has a MD from the University of Arizona College of Medicine. Dr. Ruskin R. Lines, MD currently works at the Banner Baywood Medical Center and has 3 years experience in researching dermatology at the University of Arizona College of Medicine. One of their notable works include "Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study". Published online April 1996. doi:https://doi.org/10.1016/0024-3205(96)00160-9 [PubMed]
Linkedin | BannerHealth | Health USnews

Estimated Reading Time: < 1 min read